LONDON--(BUSINESS WIRE)---- $III #AI--Strong interest in AI continued to drive cloud services growth in Europe in Q2, even as demand for managed services slowed, the ISG Index™ found.

LONDON--(BUSINESS WIRE)--The latest UK credit card data from global analytics software leader FICO provides stark evidence that consumer financial confidence remains low. Whilst spending has followed the usual seasonal drop after Easter, the average active balance is 4.7% higher year-on-year, suggesting consumers are not able to clear as much of their credit card debt. The percentage of balance paid is also trending downwards year-on-year by 5.8%. Another critical sign of financial difficulty i.

HOUSTON--(BUSINESS WIRE)--Expro (NYSE:XPRO) has been awarded a major three-year contract by Woodside Petróleo Operaciones de México, S. de R.L. de C.V. (Woodside Energy) in support of the Trion deepwater oil and gas development offshore Mexico. Under the agreement, Expro will provide industry-leading tubular running services (TRS) and cementing services for what will be Mexico's first deepwater oil production facility - a major milestone in the region's energy evolution. Woodside and Expro have.

Next-Generation Platform Combines Ultralow Power WiseEye™ AI with High-Precision IMU Motion Sensor to Enable Real-Time On-Device AI Inference at the Endpoint Next-Generation Platform Combines Ultralow Power WiseEye™ AI with High-Precision IMU Motion Sensor to Enable Real-Time On-Device AI Inference at the Endpoint

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fortrea Holdings Inc. ("Fortrea" or "the Company") (NASDAQ: FTRE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 3, 2023 and February 28, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 1, 2025.

Elon Musk on Monday said he does not support a merger between xAI and Tesla. On X, Musk suggested that Tesla plans to ask shareholders whether Tesla should invest in xAI, however.

Sysco offers a defensive, income-producing investment with a 2.8% yield and a 55-year streak of dividend increases, outpacing inflation. The company's strong balance sheet, reduced leverage, and ongoing share buybacks position it for continued dividend growth and capital returns. Sysco's improving sales force, expanding market, and international growth support my 7% EPS CAGR estimate and 12%+ total annual return outlook.

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws. Shareholders who purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 22, 2025.

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ: IOVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 9, 2024 and May 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 14, 2025.

Alibaba-backed startup Moonshot released late Friday night its Kimi K2 model as a low-cost, open source large language model, with a focus on coding capabilities. Moonshot claimed Kimi K2 surpassed Claude Opus 4 on two benchmarks, and had better overall performance than OpenAI's coding-focused GPT-4.1 model, according to several industry metrics.

AstraZeneca 's experimental drug baxdrostat has been successful in lowering high blood pressure in a late-stage study of people whose condition was hard to control or treat, the Anglo-Swedish drugmaker said on Monday, sending shares up 2%.

Kinder Morgan offers stable, fee-based revenues with 90% decoupled from commodity prices, making it a reliable cash flow generator. Strategic investments in renewable natural gas and hydrogen, plus a robust project backlog, position Kinder Morgan for steady, not explosive growth. In this earnings preview, I want to highlight some possible tailwinds that will benefit Kinder Morgan, one of which could be the result of the US-EU trade talks.

Billionaire Elon Musk said in a Monday post on X he does not support a merger between Tesla and his artificial intelligence startup xAI.

Trump's Russia sanctions may disrupt crude oil flows, driving bullish oil outlook and higher futures amid supply risk and freight bottlenecks.

Since the mid-1960s, Berkshire Hathaway's (BRK.A -0.62%) (BRK.B -0.52%) Warren Buffett has been consistently outpacing the benchmark S&P 500 in the return department. As of the closing bell on July 10, the Oracle of Omaha has overseen a cumulative return in his company's Class A shares (BRK.A) of 5,873,451% since becoming CEO.

Coca-Cola (KO 0.20%) is performing very strongly today, with organic sales up 6% in the first quarter of 2025. That comes amid a tough backdrop for consumer staples companies, thanks to inflation and consumers' worries about their finances.

Gold holds near $3,355 as rising tariffs and geopolitical risk boost safe-haven appeal. Silver outperforms, gaining 3.5% amid inflation hedging.

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that all primary and secondary endpoints were met in two Phase 3 randomized, double-blind, placebo-controlled studies of oveporexton (TAK-861), a potential first-in-class investigational oral orexin receptor 2 (OX2R)-selective agonist, in narcolepsy type 1 (NT1). NT1 is caused by the loss of orexin-producing neurons in the brain. Orexin agonists are designed to address this underlying orexin deficiency.

Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) has delivered a solid operational update from the Segilola mine in Nigeria for the second quarter, alongside a progress report on its assets in Senegal and Côte d'Ivoire. Between April and June, the company poured just under 23,000 ounces of gold.

iShares MSCI Turkey ETF offers diversified exposure to Turkey's high-growth sectors—industrials, financials, and consumer defensives—positioning it for potential upside amid economic reforms. Risks like currency depreciation, high inflation, and political instability remain significant and could undermine returns for USD-based investors. TUR's lower expense ratio and broader diversification make it more appealing than ITKY, but concentrated holdings and low liquidity add to the risk.